Literature DB >> 18065756

The tale of two domains: proteomics and genomics analysis of SMYD2, a new histone methyltransferase.

Mohamed Abu-Farha1, Jean-Philippe Lambert, Ashraf S Al-Madhoun, Fred Elisma, Ilona S Skerjanc, Daniel Figeys.   

Abstract

Very little is known about SET- and MYND-containing protein 2 (SMYD2), a member of the SMYD protein family. However, the interest in better understanding the roles of SMYD2 has grown because of recent reports indicating that SMYD2 methylates p53 and histone H3. In this study, we present a combined proteomics and genomics study of SMYD2 designed to elucidate its molecular roles. We report the cytosolic and nuclear interactome of SMYD2 using a combination of immunoprecipitation coupled with high throughput MS, chromatin immunoprecipitation coupled with high throughput MS, and co-immunoprecipitation methods. In particular, we report that SMYD2 interacted with HSP90alpha independently of the SET and MYND domains, with EBP41L3 through the MYND domain, and with p53 through the SET domain. We demonstrated that the interaction of SMYD2 with HSP90alpha enhances SMYD2 histone methyltransferase activity and specificity for histone H3 at lysine 4 (H3K4) in vitro. Interestingly histone H3K36 methyltransferase activity was independent of its interaction with HSP90alpha similar to LSD1 dependence on the androgen receptor. We also showed that the SET domain is required for the methylation at H3K4. We demonstrated using a modified chromatin immunoprecipitation protocol that the SMYD2 gain of function leads to an increase in H3K4 methylation in vivo, whereas no observable levels of H3K36 were detected. We also report that the SMYD2 gain of function was correlated with the up-regulation of 37 and down-regulation of four genes, the majority of which are involved in the cell cycle, chromatin remodeling, and transcriptional regulation. TACC2 is one of the genes up-regulated as a result of SMYD2 gain of function. Up-regulation of TACC2 by SMYD2 occurred as a result of SMYD2 binding to the TACC2 promoter where it methylates H3K4. Furthermore the combination of the SMYD2 interactome with the gene expression data suggests that some of the genes regulated by SMYD2 are closely associated with SMYD2-interacting proteins.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18065756     DOI: 10.1074/mcp.M700271-MCP200

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  91 in total

Review 1.  Understanding the language of Lys36 methylation at histone H3.

Authors:  Eric J Wagner; Phillip B Carpenter
Journal:  Nat Rev Mol Cell Biol       Date:  2012-01-23       Impact factor: 94.444

2.  Uncovering the human methyltransferasome.

Authors:  Tanya C Petrossian; Steven G Clarke
Journal:  Mol Cell Proteomics       Date:  2010-10-07       Impact factor: 5.911

3.  Crystal structure of cardiac-specific histone methyltransferase SmyD1 reveals unusual active site architecture.

Authors:  Nualpun Sirinupong; Joseph Brunzelle; Jun Ye; Ali Pirzada; Lindsey Nico; Zhe Yang
Journal:  J Biol Chem       Date:  2010-10-12       Impact factor: 5.157

Review 4.  Post-transcriptional gene silencing, transcriptional gene silencing and human immunodeficiency virus.

Authors:  Catalina Méndez; Chantelle L Ahlenstiel; Anthony D Kelleher
Journal:  World J Virol       Date:  2015-08-12

5.  The long non-coding RNA Fendrr links epigenetic control mechanisms to gene regulatory networks in mammalian embryogenesis.

Authors:  Phillip Grote; Bernhard G Herrmann
Journal:  RNA Biol       Date:  2013-08-22       Impact factor: 4.652

6.  Structure of human SMYD2 protein reveals the basis of p53 tumor suppressor methylation.

Authors:  Li Wang; Ling Li; Hailong Zhang; Xiao Luo; Jingquan Dai; Shaolian Zhou; Justin Gu; Jidong Zhu; Peter Atadja; Chris Lu; En Li; Kehao Zhao
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

7.  The chromatin-binding protein Smyd1 restricts adult mammalian heart growth.

Authors:  Sarah Franklin; Todd Kimball; Tara L Rasmussen; Manuel Rosa-Garrido; Haodong Chen; Tam Tran; Mickey R Miller; Ricardo Gray; Shanxi Jiang; Shuxun Ren; Yibin Wang; Haley O Tucker; Thomas M Vondriska
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-09-23       Impact factor: 4.733

8.  Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma.

Authors:  María Berdasco; Santiago Ropero; Fernando Setien; Mario F Fraga; Pablo Lapunzina; Régine Losson; Miguel Alaminos; Nai-Kong Cheung; Nazneen Rahman; Manel Esteller
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

9.  Cardiac deletion of Smyd2 is dispensable for mouse heart development.

Authors:  Florian Diehl; Mark A Brown; Machteld J van Amerongen; Tatyana Novoyatleva; Astrid Wietelmann; June Harriss; Fulvia Ferrazzi; Thomas Böttger; Richard P Harvey; Philip W Tucker; Felix B Engel
Journal:  PLoS One       Date:  2010-03-17       Impact factor: 3.240

10.  A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas.

Authors:  Leandro C Cerchietti; Eloisi C Lopes; Shao Ning Yang; Katerina Hatzi; Karen L Bunting; Lucas A Tsikitas; Alka Mallik; Ana I Robles; Jennifer Walling; Lyuba Varticovski; Rita Shaknovich; Kapil N Bhalla; Gabriela Chiosis; Ari Melnick
Journal:  Nat Med       Date:  2009-11-22       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.